Table 2.
HBsAg positive (n = 91) | |
---|---|
Male, n (%) | 61 (67) |
Age (years), median (IQR) | 62 (49–76) |
White, n (%) | 69 (76) |
IDU (current or history), n (%) | 2 (2) |
Alcohol consumption, n (%) | 13 (14) |
Prior transfusion of blood products, n (%) | 4 (4) |
Psychiatric disorder, n (%) | 21 (23) |
HIV coinfection, n (%) | 1 (1) |
Patients’ infection unawareness, n (%) | 37 (41) |
Anti-HCV, n (%) | 5 (5) |
ALT (IU/L), median (IQR) | 22 (14–36) |
FIB-4, median (IQR) | 1.79 (1.04–2.9) |
Late diagnosis (FIB-4 >3.25), n (%) | 18 (20) |
Hepatocellular carcinoma, n (%) | 5 (6) |
HBeAg, n (%) | 4 (4) |
Anti-HDV, n (%) | 2 (2) |
Quantitative variables were expressed as medians (IQR) because of the non-normality of the distributions previously tested with a normality test (Shapiro–Wilks).
anti-HCV, HCV antibody; anti-HDV, HDV antibody; ED, emergency department; FIB-4, Fibrosis-4; IDU, injecting drug use.